Thursday, November 09, 2017 9:14:51 AM
Authorized Shares: 2,000,000,000
Outstanding Shares: 1,906,128,206
NBC NEWS REPORT
https://www.nbcmiami.com/news/local/South-Florida-Company-Turns-Cobra-Venom-Into-Healing-Treatment-413791863.html
https://nyloxin.com
https://www.amazon.com/Nyloxin-Topical-Gel-Roll-Applicator/dp/B0089PF6AM/ref=sr_1_1_a_it?ie=UTF8&qid=1510235906&sr=8-1&keywords=NYLOXIN
NYLOXIN IS 100% SAFE TO TREAT CHRONIC ARTHRITIS AND JOINT PAIN
Nyloxin is believed to work by targeting some of the same receptors on nerve cells that are also recognized by nicotine. These receptors are found in nerves outside the central nervous system (brain and spinal cord) and they are also found on cells of the immune system. Specialized proteins in Nyloxin block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off. In some clinical studies, Nyloxin pain relieving products could provide prolonged chronic muscle and joint relief.
PENDING NEWS FOR UPCOMING DRUGS ON MULTIPLE SCLEROSIS, HIV, RHEUMATOID ARTHRITIS, Adrenal Myelin Neuropathy AND PAIN.
NPHC:Newbie DD CREDIT TO IHUB MEMBER "ZINO" FOR DD BELOW
CLINICAL TRIALS DD BELOW
O/S 1.65 Billion ( UPDATED: 1.906bill as of NOV 8th 2017 per TA)
Standard Registrar and Transfer Co., Inc. 801-571-8844
https://www.otcmarkets.com/research/service-provider/Standard-Registrar-and-Transfer-Co.-Inc.?id=2433&b=n&filterOn=6
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration
https://finance.yahoo.com/news/nutra-pharmas-rpi-78m-granted-123000069.html
Collaboration: University of Maryland,production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple Sclerosis
https://finance.yahoo.com/news/nutra-pharma-announces-collaboration-university-123000318.html
We expect to begin the trial in FY-2017 for a Phase I/II trial for the use of RPI–78M in the treatment of Pediatric Multiple Sclerosis.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12232075
1O Different Drugs in Testing
http://www.receptopharm.com/drug_development/pipeline.php
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM